Knowing the imprinted profiles of naїve CD4+ T cells, which have a pivotal role in the onset and development of autoimmune diseases, it may lead, in healthy and pathogenic conditions, to a new field of study not only in the search for therapeutic targets, but also as a risk or prognostic tool. This evidence concerns the gene CD4 and autoimmune disease.